Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 26 of 26 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park | |
Company Astellas Gene Therapies | Activity: Production and Manufacturing | Company Description Astellas Gene Therapies manufactures AAV gene therapy products for rare diseases. | Location Sanford | |
Company Bavarian Nordic Inc. | Activity: Research and Development | Company Description Bavarian Nordic develops, manufactures and commercializes vaccines for infectious diseases. | Location Durham | |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham | |
Company Biogen | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. The Drug Substance Campus in RTP is home to biologics production and a patient services contact center. | Location Research Triangle Park | |
Company Biogen (Oral Solid Dose Facility) | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. This site houses oral solid dose and anti-sense oligonucleotide production, packaging and fill/finish operations, as well as a Global Business Services center. | Location Research Triangle Park | |
Company Chiesi USA Inc. | Activity: Research and Development | Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. | Location Cary | |
Company CSL Seqirus | Activity: Production and Manufacturing | Company Description Seqirus manufactures influenza vaccines using both egg-based and cell-based technologies. | Location Holly Springs | |
Company Glenmark Pharmaceuticals Inc., USA | Activity: Production and Manufacturing | Company Description Glenmark Pharmaceuticals discovers small-molecule drugs and biologics in the areas of oncology, respiratory disease and dermatology, and manufactures and distributes APIs and generics. The Monroe site manufactures oral solids, injectables and topicals. | Location Monroe | |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham | |
Company KBI Biopharma Inc. (Corporate HQ) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. | Location Durham | |
Company KBI Biopharma Inc. (Patriot Park Facility) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. The Patriot Park Facility is a 150,000 square-foot cGMP biologics manufacturing facility. | Location Durham | |
Company KBI Biopharma Inc. (Venture Center Facility) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services. KBI's Venture Center Facility conducts process and analytical development, process characterization and cell line development. | Location Durham | |
Company Kriya Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, thyroid eye disease (TED) and other indications. This location is the company's internal manufacturing facility. | Location Morrisville | |
Company Merck & Co. Inc. (Durham) | Activity: Production and Manufacturing | Company Description Merck manufactures vaccine products at its Durham facility. | Location Durham | |
Company Merck & Co. Inc. (Wilson) | Activity: Production and Manufacturing | Company Description Merck's Wilson facility produces patented prescription products and performs granulation and tableting operations. | Location Wilson | |
Company Novo Nordisk Pharmaceutical Industries LP (API facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Active Pharmaceutical Ingredient (API) facility produces the API for an oral diabetes treatment through fermentation, purification and recovery processes. | Location Clayton | |
Company Novo Nordisk Pharmaceutical Industries LP (Durham) | Activity: Production and Manufacturing | Company Description Novo Nordisk manufactures tablets for an oral GLP-1 treatment for type 2 diabetes. | Location Durham | |
Company Novo Nordisk Pharmaceutical Industries LP (IFP facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes. | Location Clayton | |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Durham | |
Company Precision Biosciences Manufacturing Center for Advanced Therapeutics (RTP) | Activity: Production and Manufacturing | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Research Triangle Park | |
Company Prinston Laboratories | Activity: Production and Manufacturing | Company Description Prinston Laboratories manufactures generic pharmaceuticals. | Location Charlotte | |
Company Resilience (Durham) | Activity: Production and Manufacturing | Company Description Resilience manufactures viral vectors, a component of cell and gene therapies. | Location Durham | |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham | |
Company TARGAN Inc. | Activity: Research and Development | Company Description TARGAN is developing automated bio-system solutions for detecting, targeting, and delivering vaccines for the animal health industry. TARGAN's technologies aim to reduce the need for antibiotics by improving vaccination delivery. | Location Raleigh | |
Company Tergus Pharma LLC | Activity: Production and Manufacturing | Company Description Tergus Pharma provides contract services for topical pharmaceuticals, including research, drug development, and testing to scale-up and commercial manufacturing. | Location Durham |